title: "Early" withdrawal of glucocorticosteroids is well tolerated by kidney transplant recipients without increasing allograft rejection while preserving bone integrity.
authors.affiliation: 1 Nephrology Division, Department of Medicine, State University of New York, Downstate Medical Center, Brooklyn, NY. 2 Address correspondence to: Eli A. Friedman, M.D., Department of Medicine, Downstate Medical Center, 450 Clarkson Avenue, Brooklyn, New York 11203.
authors.forename: Eli A
authors.initials: EA
authors.lastname: Friedman
mesh_terms: D000328:Adult; D064591:Allografts; D001842:Bone and Bones / Q000187:drug effects* / Q000473:pathology; D002117:Calcitriol / Q000378:metabolism; D005260:Female; D000089703:Fibroblast Growth Factor-23; D005346:Fibroblast Growth Factors / Q000378:metabolism; D005938:Glucocorticoids / Q000008:administration & dosage* / Q000627:therapeutic use; D006084:Graft Rejection; D006801:Humans; D006961:Hyperparathyroidism / Q000188:drug therapy; D007166:Immunosuppressive Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D007676:Kidney Failure, Chronic / Q000601:surgery*; D016030:Kidney Transplantation; D008297:Male; D008875:Middle Aged; D012307:Risk Factors; D013256:Steroids / Q000008:administration & dosage / Q000627:therapeutic use
chemical_list: D005938:Glucocorticoids; D007166:Immunosuppressive Agents; D013256:Steroids; D005346:Fibroblast Growth Factors; D000089703:Fibroblast Growth Factor-23; D002117:Calcitriol